Tags |
|
|
Links |
|
|
Just Other Articles - Medical Billing - GX0 Record Fields 14 Through 19
If you're planning on doing medical billing and sending in claims for oxygen, you better make sure you've had plenty of sleep the night before.
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
Oxygen billing is probably the most complex of all the medical billing procedures because of certain conversions and calculations that need t
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
be done in regard to the oxygen itself. In this installment of our series on medical billing and the electronic transmission of claims using
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
NSF 3.01 specifications, we'll be covering the GX0 record, picking up with field number 14.
GX0 field 14, positions 125 - 127, is the oxygen f
GX0 field 14, positions 125 - 127, is the oxygen f
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ow rate. This tells the carrier how many liters per minute the patient is supposed to receive. The valid values are 001 - 999. If the patien
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
is going to be getting less than one liter per minute than the software needs to enter 00X.
There are some notes that are important about thi
There are some notes that are important about thi
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
s field, as it is one of the most important fields on this CMN.
If you're billing for an oxygen concentrator, the concentrator being given to
If you're billing for an oxygen concentrator, the concentrator being given to
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
he patient must go along with the flow rate prescribed by the doctor. This is especially critical when billing for flows greater than 4 liters
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
per minute and less than 1 liter per minute. Also, if you're billing oxygen for a flow rate greater than 4 liters per minute, the date the te
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
t was performed must be filled in. Use field GX0-20 for this. Also, flows of greater than 2 liters per minute will usually require a review b
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
the insurance companies medical staff.
GX0 field 15, positions 128 - 129, is the frequency of use. This field tells the carrier how many tim
GX0 field 15, positions 128 - 129, is the frequency of use. This field tells the carrier how many tim
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
es per day the patient is to use the oxygen. Just a note. This field is usually only filled in if the doctor prescribed oxygen use during cer
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ain times, such as when the patient is exercising, sleeping, etc.
GX0 field 16, positions 130 - 131, is the duration of use. This field tells
GX0 field 16, positions 130 - 131, is the duration of use. This field tells
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
the carrier how long in hours the patient is to use the oxygen for each use. If the number of hours is less than 10, then the field needs to
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
e left zero filled. So 4 hours would be transmitted as 04.
GX0 field 17, positions 132 - 134, is the arterial blood gas at 4 LPM. This field
GX0 field 17, positions 132 - 134, is the arterial blood gas at 4 LPM. This field
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
tells the carrier what the blood tests results were for arterial gas when the patient was given oxygen at a rate of 4 liters per minute.
GX0 f
GX0 f
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ield 18, positions 135 - 137, is the oxygen saturation at 4 LPM. This field tells the carrier what the blood test results were for oxygen satu
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ation when the patient was given oxygen at a rate of 4 liters per minute.
GX0 field 19, positions 138 - 145, is the date the patient was teste
GX0 field 19, positions 138 - 145, is the date the patient was teste
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
d on 4 LPM. This field tells the carrier the date that the patient was tested for the 4 LPM tests. This date can be transmitted as yyyymmdd o
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
mmddyyyy, depending on the carrier requirements.
In our next installment of medical billing, we'll continue with our review of the GX0 record
In our next installment of medical billing, we'll continue with our review of the GX0 record
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/2088/justotherarticles-Medical-Billing--GX0-Record-Fields-14-Through-19.html">Medical Billing - GX0 Record Fields 14 Through 19</a>
BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/2088/justotherarticles-Medical-Billing--GX0-Record-Fields-14-Through-19.html]Medical Billing - GX0 Record Fields 14 Through 19[/url]
Related Articles:
Use The Right Benefit Statements on Your Website (and in All Your Marketing)
Bookmark it:
|